Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

165 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
Kashiwagi A, Shoji S, Kosakai Y, Koga T, Asakawa K, Rokuda M. Kashiwagi A, et al. Among authors: kosakai y. J Diabetes Investig. 2023 Mar;14(3):404-416. doi: 10.1111/jdi.13952. Epub 2022 Dec 14. J Diabetes Investig. 2023. PMID: 36515129 Free PMC article.
Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan.
Kashiwagi A, Shoji S, Onozawa S, Kosakai Y, Waratani M, Ito Y. Kashiwagi A, et al. Among authors: kosakai y. J Diabetes Investig. 2022 Jul;13(7):1175-1189. doi: 10.1111/jdi.13785. Epub 2022 Apr 9. J Diabetes Investig. 2022. PMID: 35243799 Free PMC article.
Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials.
Kashiwagi A, Yoshida S, Nakamura I, Kazuta K, Ueyama E, Takahashi H, Satomi H, Kosakai Y, Kawamuki K. Kashiwagi A, et al. Among authors: kosakai y. J Diabetes Investig. 2016 Jul;7(4):544-54. doi: 10.1111/jdi.12471. Epub 2016 Mar 1. J Diabetes Investig. 2016. PMID: 27181576 Free PMC article. Clinical Trial.
Improved cardiometabolic risk factors in Japanese patients with type 2 diabetes treated with ipragliflozin: a pooled analysis of six randomized, placebo-controlled trials.
Kashiwagi A, Sakatani T, Nakamura I, Akiyama N, Kazuta K, Ueyama E, Takahashi H, Kosakai Y. Kashiwagi A, et al. Among authors: kosakai y. Endocr J. 2018 Jul 28;65(7):693-705. doi: 10.1507/endocrj.EJ17-0491. Epub 2018 May 29. Endocr J. 2018. PMID: 29848902 Free article. Clinical Trial.
165 results